Recession fears, inflation, and aggressive monetary policy continue to affect the stock market’s performance. However, irrespective of broader economic conditions, medical stocks tend to be recession-resistant and usually perform well due to the inelastic demand for medical products and services.
Moreover, growing competition and technological innovations and adoptions are expected to continue boosting hospital companies’ efficiency in the upcoming term. On top of it, an aging population and increasing prevalence of chronic diseases will likely brighten the industry’s prospects.
